 |
|
|
|
|
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2022 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Iovance Biotherapeutics, Inc.
| | | | | Phone: | (212) 946-4856 | | Ticker: | IOVA | | Exchange: | NASDAQ | | Main Contact: | Maria Fardis, PhD, MBA, President & CEO | | | | Company Description | | Iovance Biotherapeutics focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL). | |
|
|
|
|
|
|
|
